Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Exisulind in Prostate Cancer
NCT00166478Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Apr 2002
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of exisulind in prostate cancer (PCa), sponsored by Mayo Clinic. Started Apr 2002; status: completed.
02
Drugs
exisulind
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00166478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00166478.